Arthros

Anti-interleukin-1.alpha. Immunoglobulin G Rabbit, .alpha.-ketoglutaric Acid, .alpha.-lipoic Acid, Apomorphine, Bos Taurus Joint Capsule, Sus Scrofa Joint Capsule, Ascorbic Acid, Bos Taurus Adrenal Gland, Sus Scrofa Adrenal Gland, Brain-derived Neurotrophic Factor Human, Metenkefalin, Ersofermin, Bos Taurus Solar Plexus, Sus Scrofa Solar Plexus, Calcitonin, Bos Taurus Cartilage, Sus Scrofa Cartilage, Colchicum Autumnale Bulb, Pork Collagen, Bos Taurus Red Blood Cell, Sus Scrofa Red Blood Cell


Viatrexx Bio Incorporated
Human Otc Drug
NDC 63776-035
Arthros also known as Anti-interleukin-1.alpha. Immunoglobulin G Rabbit, .alpha.-ketoglutaric Acid, .alpha.-lipoic Acid, Apomorphine, Bos Taurus Joint Capsule, Sus Scrofa Joint Capsule, Ascorbic Acid, Bos Taurus Adrenal Gland, Sus Scrofa Adrenal Gland, Brain-derived Neurotrophic Factor Human, Metenkefalin, Ersofermin, Bos Taurus Solar Plexus, Sus Scrofa Solar Plexus, Calcitonin, Bos Taurus Cartilage, Sus Scrofa Cartilage, Colchicum Autumnale Bulb, Pork Collagen, Bos Taurus Red Blood Cell, Sus Scrofa Red Blood Cell is a human otc drug labeled by 'Viatrexx Bio Incorporated'. National Drug Code (NDC) number for Arthros is 63776-035. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Arthros drug includes .alpha.-ketoglutaric Acid - 30 [kp_C]/mL .alpha.-lipoic Acid - 30 [kp_C]/mL Anti-interleukin-1.alpha. Immunoglobulin G Rabbit - 200 [kp_C]/mL Apomorphine - 30 [kp_C]/mL Ascorbic Acid - 30 [kp_C]/mL Beef Liver - 200 [kp_C]/mL Bos Taurus Adrenal Gland - 200 [kp_C]/mL Bos Taurus Cartilage - 200 [kp_C]/mL Bos Taurus Joint Capsule - 200 [kp_C]/mL Bos Taurus Lymph - 200 [kp_C]/mL and more. The currest status of Arthros drug is Active.

Drug Information:

Drug NDC: 63776-035
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Arthros
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Anti-interleukin-1.alpha. Immunoglobulin G Rabbit, .alpha.-ketoglutaric Acid, .alpha.-lipoic Acid, Apomorphine, Bos Taurus Joint Capsule, Sus Scrofa Joint Capsule, Ascorbic Acid, Bos Taurus Adrenal Gland, Sus Scrofa Adrenal Gland, Brain-derived Neurotrophic Factor Human, Metenkefalin, Ersofermin, Bos Taurus Solar Plexus, Sus Scrofa Solar Plexus, Calcitonin, Bos Taurus Cartilage, Sus Scrofa Cartilage, Colchicum Autumnale Bulb, Pork Collagen, Bos Taurus Red Blood Cell, Sus Scrofa Red Blood Cell
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Viatrexx Bio Incorporated
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Spray
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:.ALPHA.-KETOGLUTARIC ACID - 30 [kp_C]/mL
.ALPHA.-LIPOIC ACID - 30 [kp_C]/mL
ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT - 200 [kp_C]/mL
APOMORPHINE - 30 [kp_C]/mL
ASCORBIC ACID - 30 [kp_C]/mL
BEEF LIVER - 200 [kp_C]/mL
BOS TAURUS ADRENAL GLAND - 200 [kp_C]/mL
BOS TAURUS CARTILAGE - 200 [kp_C]/mL
BOS TAURUS JOINT CAPSULE - 200 [kp_C]/mL
BOS TAURUS LYMPH - 200 [kp_C]/mL
BOS TAURUS MESENCHYME - 200 [hp_Q]/mL
BOS TAURUS PARATHYROID GLAND - 200 [kp_C]/mL
BOS TAURUS PLACENTA - 30 [kp_C]/mL
BOS TAURUS RED BLOOD CELL - 200 [kp_C]/mL
BOS TAURUS SOLAR PLEXUS - 200 [kp_C]/mL
BOS TAURUS VEIN - 30 [kp_C]/mL
BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN - 200 [kp_C]/mL
CALCITONIN - 200 [kp_C]/mL
COLCHICUM AUTUMNALE BULB - 200 [kp_C]/mL
EDODEKIN ALFA - 200 [kp_C]/mL
ERSOFERMIN - 200 [kp_C]/mL
INTERFERON GAMMA-1A - 200 [kp_C]/mL
METENKEFALIN - 200 [kp_C]/mL
NADIDE - 30 [kp_C]/mL
PORK COLLAGEN - 200 [kp_C]/mL
PORK LIVER - 200 [kp_C]/mL
QUINHYDRONE - 30 [kp_C]/mL
SULFUR - 30 [kp_C]/mL
SUS SCROFA ADRENAL GLAND - 200 [kp_C]/mL
SUS SCROFA CARTILAGE - 200 [kp_C]/mL
SUS SCROFA JOINT CAPSULE - 200 [kp_C]/mL
SUS SCROFA LYMPH - 200 [kp_C]/mL
SUS SCROFA MESENCHYME - 200 [hp_Q]/mL
SUS SCROFA PARATHYROID GLAND - 200 [kp_C]/mL
SUS SCROFA RED BLOOD CELL - 200 [kp_C]/mL
SUS SCROFA SOLAR PLEXUS - 200 [kp_C]/mL
SUS SCROFA VEIN - 30 [kp_C]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 24 Jul, 2012
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 13 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:VIATREXX BIO INCORPORATED
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
NUI:N0000000117
N0000175580
N0000193618
M0001797
N0000185371
N0000175629
N0000184306
M0000728
M0006342
N0000185017
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:8ID597Z82X
73Y7P0K73Y
ML4QRZ1HCL
N21FAR7B4S
PQ6CK8PD0R
W8N8R55022
M2776SWB29
UE77B10IIY
782I3O9VSM
UGE0WQC19W
3802H34QRI
SMV71DDI4T
83AL37E3A7
5W4FLB0U2C
Y8H8S1X8IB
3H31IR83LT
A1ED6W905I
DF35I47HCM
993QHL78E6
31Z82G8ME1
1NWT5SW3NW
VC9M78242P
9JEZ9OD3AS
0U46U6E8UK
I8442U2G7J
6EC706HI7F
P4A66LQ3QJ
70FD1KFU70
398IYQ16YV
73ECW5WG2F
LX0XHE5NLN
33A7VYU29L
UH52A16DZB
2KBE35NE8S
5X23IGF970
WN6M3MGG1X
2510RH3I89
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class MOA:Dopamine Agonists [MoA]
Mechanism of action of the drug—molecular, subcellular, or cellular functional activity—of the drug’s established pharmacologic class. Takes the form of the mechanism of action, followed by `[MoA]` (such as `Calcium Channel Antagonists [MoA]` or `Tumor Necrosis Factor Receptor Blocking Activity [MoA]`.
Pharmacologic Class EPC:Dopaminergic Agonist [EPC]
Vitamin C [EPC]
Non-Standardized Food Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:Increased Histamine Release [PE]
Cell-mediated Immunity [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:Ascorbic Acid [CS]
Allergens [CS]
Dietary Proteins [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:Allergens [CS]
Ascorbic Acid [CS]
Cell-mediated Immunity [PE]
Depigmenting Activity [PE]
Dietary Proteins [CS]
Dopamine Agonists [MoA]
Dopaminergic Agonist [EPC]
Increased Histamine Release [PE]
Meat Proteins [EXT]
Melanin Synthesis Inhibitor [EPC]
Melanin Synthesis Inhibitors [MoA]
Non-Standardized Food Allergenic Extract [EPC]
Vitamin C [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
63776-035-141 BOTTLE, SPRAY in 1 BOX (63776-035-14) / 30 mL in 1 BOTTLE, SPRAY24 Jul, 2012N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose: anti-interleukin 1 anti-inflammation alpha ketoglutaric acid cell respiration alpha lipoic acid anti-aging apomorphine pain relief articulation capsule regeneration ascorbic acid anti-oxidant adrenal adrenal support bdnf regeneration beta endorphin pain relief bfgf regeneration coelliac plexus neurological support calcitonin calcium balance cartilage regeneration colchicum automnale drainage collagen regeneration erythrocytes immune support interleukin-12 immune support interferon gamma immune support liver drainage lymph node immune support mesenchyme regeneration nadid cell respiration parathyroid regeneration placenta regeneration quinhydrone citric cycle support sulphur drainage vein regeneration

Product Elements:

Arthros anti-interleukin-1.alpha. immunoglobulin g rabbit, .alpha.-ketoglutaric acid, .alpha.-lipoic acid, apomorphine, bos taurus joint capsule, sus scrofa joint capsule, ascorbic acid, bos taurus adrenal gland, sus scrofa adrenal gland, brain-derived neurotrophic factor human, metenkefalin, ersofermin, bos taurus solar plexus, sus scrofa solar plexus, calcitonin, bos taurus cartilage, sus scrofa cartilage, colchicum autumnale bulb, pork collagen, bos taurus red blood cell, sus scrofa red blood cell alcohol water anti-interleukin-1.alpha. immunoglobulin g rabbit anti-interleukin-1.alpha. immunoglobulin g rabbit .alpha.-ketoglutaric acid .alpha.-ketoglutaric acid .alpha.-lipoic acid .alpha.-lipoic acid apomorphine apomorphine bos taurus joint capsule bos taurus joint capsule sus scrofa joint capsule sus scrofa joint capsule ascorbic acid ascorbic acid bos taurus adrenal gland bos taurus adrenal gland sus scrofa adrenal gland sus scrofa adrenal gland brain-derived neurotrophic factor human brain-derived neurotrophic factor human metenkefalin metenkefalin ersofermin ersofermin bos taurus solar plexus bos taurus solar plexus sus scrofa solar plexus sus scrofa solar plexus calcitonin calcitonin bos taurus cartilage bos taurus cartilage sus scrofa cartilage sus scrofa cartilage colchicum autumnale bulb colchicum autumnale bulb pork collagen pork collagen bos taurus red blood cell bos taurus red blood cell sus scrofa red blood cell sus scrofa red blood cell edodekin alfa edodekin alfa interferon gamma-1a interferon gamma-1a beef liver beef liver pork liver pork liver bos taurus lymph bos taurus lymph sus scrofa lymph sus scrofa lymph bos taurus mesenchyme bos taurus mesenchyme sus scrofa mesenchyme sus scrofa mesenchyme nadide nadide bos taurus parathyroid gland bos taurus parathyroid gland sus scrofa parathyroid gland sus scrofa parathyroid gland bos taurus placenta bos taurus placenta quinhydrone hydroquinone sulfur sulfur bos taurus vein bos taurus vein sus scrofa vein sus scrofa vein

Indications and Usage:

Uses for the relief of arthritic symptoms

Warnings:

Warnings stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. if pregnant or breastfeeding, ask a health care practitioner before use.

Dosage and Administration:

Dosage 1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.

Package Label Principal Display Panel:

Principal display panel item: vpc0030 ndc 63776-035-14 homeopathic remedy arthros • for the relief of arthritic symptoms oral spray 30ml 1 oz viatrexx ™ bio incorporated manufactured by viatrexx www.viatrexx.com newark, de 19713 arthros 30 ml 1 oz viatrexx ™ bio incorporated item: vpc0030 ndc: 63776-035-14 indications: for the relief of arthritic symptoms directions: 1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner. mfg. for viatrexx bio incorporated www.viatrexx.com newark, de 19713 arthros carton ingredients

Further Questions:

Questions info@viatrexx.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.